Archive for November 2024
PubMed: SeptAsTERS- SeptiCyte® RAPID as assessment tool for early recognition of sepsis – a prospective observational study
Via PubMed 2024 Nov 22. doi: 10.1007/s15010-024-02409-4. Online ahead of print. SeptAsTERS- SeptiCyte® RAPID as assessment tool for early recognition of sepsis – a prospective observational study M von der Forst 1, L Back 1, K M Tourelle 1, D Gruneberg 1, M A Weigand 1, F C F Schmitt 1, Maximilian Dietrich 2 Affiliations PMID: 39576568 DOI: 10.1007/s15010-024-02409-4 Abstract Purpose: Early recognition of sepsis is critical to patient outcome, with…
Read MoreUtility of a Host Response Sepsis Diagnostic Assay for Longitudinal Monitoring of Sepsis Patients: A Case Study
Original source: https://septicyte.com/wp-content/uploads/2024/11/IMM-061-Gastrointeritis-8.5×11-03-01-SC-No-Crops.pdf LB-9076 – UTILITY OF A HOST RESPONSE SEPSIS DIAGNOSTIC ASSAY FOR LONGITUDINAL MONITORING OF SEPSIS PATIENTS – A CASE STUDY
Read MoreAssay for Longitudinal Monitoring in Severe Maliaria: A Case Study
Original source: https://septicyte.com/wp-content/uploads/2024/11/IMM-061-Malaria-8.5×11-03-01-SC-No-Crops.pdf LB-9416 – ASSAY FOR LONGITUDINAL MONITORING IN SEVERE MALARIA – A CASE STUDY
Read MoreInterview with Dr. Rollie Carlson on NPR’s Bio Tech Nation
Rollie’s interview with Moira Gunn of NPR Bio Tech Nation has been published. You can listen to the interview here: https://www.biotechnation.com/episodes/dr-rollie-carlson-ceo-immunexpress
Read More